Amsterdam - Delayed Quote EUR

DSM-Firmenich AG (DSFIR.AS)

94.52
-0.40
(-0.42%)
At close: May 12 at 5:35:02 PM GMT+2
Loading Chart for DSFIR.AS
  • Previous Close 94.92
  • Open 95.90
  • Bid --
  • Ask --
  • Day's Range 93.86 - 95.96
  • 52 Week Range 82.56 - 124.85
  • Volume 526,977
  • Avg. Volume 529,750
  • Market Cap (intraday) 25.248B
  • Beta (5Y Monthly) 1.04
  • PE Ratio (TTM) 100.55
  • EPS (TTM) 0.94
  • Earnings Date Jul 31, 2025
  • Forward Dividend & Yield 2.50 (2.64%)
  • Ex-Dividend Date May 8, 2025
  • 1y Target Est 122.72

DSM-Firmenich AG provides nutrition, health, and beauty solutions in Switzerland, the Netherlands, rest of Europe, the Middle East and Africa, North America, Latin America, China, and rest of Asia. The company operates through four segments: Perfumery & Beauty; Taste, Texture & Health; Health, Nutrition & Care; and Animal Nutrition & Health. The Perfumery & Beauty creates scents using natural, synthetic, and biotech ingredients. The Taste, Texture & Health segment provides food and beverages solutions, including flavors, natural extracts, and sugar reduction; and food enzymes, hydrocolloids, cultures, natural colorants, nutritional ingredients, and plant-based proteins. The Health, Nutrition & Care segment provides solutions for the early life nutrition, dietary supplement, pharmaceutical, medical nutrition, biomedical materials, and nutrition improvement markets. This segment also offers vitamins, nutritional lipids, minerals, carotenoids, botanical nutraceuticals, digestive enzymes, postbiotics, probiotics and prebiotics, and active pharmaceutical ingredients; biomedical solutions; and premix, market-ready, and personalized nutrition solutions, as well as expert services in regulatory affairs and nutrition. The Animal Nutrition & Health segment offers animal proteins, vitamins, performance solutions, and data-driven precision services. The company was founded in 1902 and is based in Kaiseraugst, Switzerland.

www.dsm-firmenich.com

26,301

Full Time Employees

December 31

Fiscal Year Ends

Recent News: DSFIR.AS

View More

Performance Overview: DSFIR.AS

Trailing total returns as of 5/12/2025, which may include dividends or other distributions. Benchmark is AEX-Index (^AEX) .

YTD Return

DSFIR.AS
0.64%
AEX-Index (^AEX)
4.95%

1-Year Return

DSFIR.AS
5.83%
AEX-Index (^AEX)
1.26%

3-Year Return

DSFIR.AS
16.35%
AEX-Index (^AEX)
36.59%

5-Year Return

DSFIR.AS
16.35%
AEX-Index (^AEX)
77.17%

Compare To: DSFIR.AS

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Statistics: DSFIR.AS

View More

Valuation Measures

As of 5/9/2025
  • Market Cap

    25.11B

  • Enterprise Value

    27.67B

  • Trailing P/E

    100.98

  • Forward P/E

    19.30

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    1.96

  • Price/Book (mrq)

    1.12

  • Enterprise Value/Revenue

    2.16

  • Enterprise Value/EBITDA

    15.47

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    1.95%

  • Return on Assets (ttm)

    0.93%

  • Return on Equity (ttm)

    1.22%

  • Revenue (ttm)

    12.8B

  • Net Income Avi to Common (ttm)

    250M

  • Diluted EPS (ttm)

    0.94

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    2.72B

  • Total Debt/Equity (mrq)

    23.26%

  • Levered Free Cash Flow (ttm)

    596.88M

Research Analysis: DSFIR.AS

View More

People Also Watch